For sure, thank you.
Two working groups were created, coming out of last fall's sheep value chain round table, one was the expansion working group. They have just started to establish action items or limiting factors on expansion. As a result, one of those is the access to medications. There are production-limiting diseases that we struggle with in this country. We don't necessarily have access to vaccinations that can be used as a preventive measure so that every birth actually makes it to something on the table.
Right now, we don't experience that. We have production-limiting diseases that slow down production. We are also experiencing very high prices, which makes it a challenge for producers to expand their flocks. You can’t keep replacement ewe lambs back and send them for slaughter at the same time.
What can the government do to help? We're working with government to get access to those medications. We're working with the veterinary drugs directorate, but also with the Canadian Animal Health Institute, which is, from my understanding, all the drug companies at the same place. We know what products are available in other parts of the world, and just getting access to those and getting distribution.
Coming back to the lack of size of our industry, there isn't always a huge incentive for those companies to bring a product to Canada to put on the shelf. That's a hurdle we are attempting to get over right now because there are provisions that state we can use science from other countries. That's huge—using that science from other countries so that the drug company doesn't have to go through all the hoops to get it approved here in Canada. They can use the science from Australia or from the United States to make a product available on the shelves here for producers.